HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johann W Bauer Selected Research

Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)

11/2018Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex.
1/2018Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.
5/2013Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study.
4/2013Imbalance of intermediate filament component keratin 14 contributes to increased stress signalling in epidermolysis bullosa simplex.
1/2013MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex.
2/2012Gene expression analysis of an epidermolysis bullosa simplex Dowling-Meara cell line by subtractive hybridization: recapitulation of cellular differentiation, migration and wound healing.
7/2011Epidermolysis bullosa with late-onset muscular dystrophy and plectin deficiency.
12/2010K14 mRNA reprogramming for dominant epidermolysis bullosa simplex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johann W Bauer Research Topics

Disease

14Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
01/2022 - 01/2009
14Epidermolysis Bullosa
01/2022 - 01/2003
12Neoplasms (Cancer)
01/2022 - 02/2011
8Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
11/2018 - 12/2010
6Blister (Bulla)
01/2021 - 01/2003
6Skin Diseases (Skin Disease)
01/2021 - 03/2008
5Wounds and Injuries (Trauma)
11/2021 - 12/2010
4Bullous Pemphigoid (Pemphigoid)
01/2021 - 09/2004
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2019 - 12/2013
3Melanoma (Melanoma, Malignant)
08/2021 - 10/2017
3Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
03/2021 - 10/2018
3Inborn Genetic Diseases (Disease, Hereditary)
03/2018 - 06/2012
2Skin Neoplasms (Skin Cancer)
01/2022 - 12/2013
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2018
2Pain (Aches)
11/2021 - 10/2019
2Edema (Dropsy)
06/2007 - 03/2007
1Pyoderma
01/2022
1Pruritus (Itching)
11/2021
1Vitiligo
01/2021
1Neoplasm Metastasis (Metastasis)
10/2020
1Atopic Dermatitis (Atopic Eczema)
01/2020
1Genetic Skin Diseases
01/2019
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Carcinogenesis
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2017
1Crohn Disease (Crohn's Disease)
09/2016
1Ulcerative Colitis
09/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2016
1Pemphigus (Pemphigus Vulgaris)
09/2016
1Fibrosis (Cirrhosis)
12/2015
1Inflammation (Inflammations)
12/2015
1Cicatrix (Scar)
12/2015
1Autistic Disorder (Autism)
02/2014
1Autoimmune Diseases (Autoimmune Disease)
06/2012
1Muscular Dystrophies (Muscular Dystrophy)
07/2011

Drug/Important Bio-Agent (IBA)

6Collagen Type VIIIBA
11/2021 - 01/2011
6Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2004
6Messenger RNA (mRNA)IBA
10/2021 - 12/2010
4AntigensIBA
10/2021 - 09/2004
4diacereinIBA
10/2019 - 05/2013
4Peptides (Polypeptides)IBA
10/2018 - 06/2007
4Keratin-14 (Keratin 14)IBA
04/2013 - 12/2010
3calcipotriene (calcipotriol)FDA LinkGeneric
11/2021 - 01/2018
3Nonsense Codon (Nonsense Mutation)IBA
10/2018 - 03/2008
3RNA (Ribonucleic Acid)IBA
01/2018 - 03/2016
2Pharmaceutical PreparationsIBA
01/2022 - 01/2021
2Collagen Type XVIIIBA
03/2021 - 09/2004
2MicroRNAs (MicroRNA)IBA
01/2021 - 10/2020
2Cetuximab (Erbitux)FDA Link
01/2019 - 01/2019
2Laminin (Merosin)IBA
01/2019 - 01/2013
2KalininIBA
10/2018 - 09/2004
2Tumor Biomarkers (Tumor Markers)IBA
01/2018 - 12/2013
2Interleukin-8 (Interleukin 8)IBA
01/2013 - 01/2003
2PlectinIBA
07/2011 - 03/2008
2GalaninIBA
06/2007 - 03/2007
1ProdrugsIBA
01/2022
1Ganciclovir (Cytovene)FDA LinkGeneric
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1antineoplaston A10 (A 10)IBA
01/2022
1Cholecalciferol (Vitamin D3)FDA Link
11/2021
1CalciumIBA
11/2021
1Ointments (Pastes)IBA
11/2021
1DNA VaccinesIBA
10/2021
1EpitopesIBA
10/2021
1Complement System Proteins (Complement)IBA
10/2021
1Cancer VaccinesIBA
10/2021
1AntibodiesIBA
08/2021
1Antisense OligonucleotidesIBA
03/2021
1LigandsIBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2021
1Immunoglobulin E (IgE)IBA
01/2020
1Monoclonal AntibodiesIBA
10/2019
1ON 01910IBA
01/2019
1Gentamicins (Gentamicin)FDA LinkGeneric
10/2018
1AnionsIBA
10/2018
1Thymidine KinaseIBA
10/2018
1Carbonic Anhydrase IXIBA
01/2018
1APOBEC DeaminasesIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Lactic Acid (Lactate)FDA LinkGeneric
01/2018
1Lactate Dehydrogenase 5IBA
01/2018
1IpilimumabIBA
10/2017
1Immunoglobulin A (IgA)IBA
09/2016
1TenascinIBA
12/2015
1Interleukin-6 (Interleukin 6)IBA
12/2015
1CollagenIBA
06/2015
1RNA Precursors (Precursor, mRNA)IBA
12/2013
1JNK Mitogen-Activated Protein KinasesIBA
04/2013
1Extracellular Matrix ProteinsIBA
01/2013
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2013
1Keratin-5 (Keratin 5)IBA
01/2013

Therapy/Procedure

17Therapeutics
01/2022 - 11/2004
2Immunotherapy
01/2021 - 10/2019
2Transplantation
11/2017 - 01/2017
1Organ Transplantation
01/2022
1Radiotherapy
01/2022
1Palliative Care (Palliative Therapy)
10/2019
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2015